This company has been marked as potentially delisted and may not be actively trading. Poseida Therapeutics (PSTX) Earnings Date, Estimates & Call Transcripts Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrendsBuy This Stock Poseida Therapeutics Earnings Summary Latest Q3 Earnings DateNov. 7EstimatedConsensus EPS (Nov. 7) -$0.42 Actual EPS (Nov. 7) $0.21 Beat By $0.63 Actual Revenue (Nov. 7) $71.75MPoseida Therapeutics released Q3 2024 earnings on November 7, 2024, reporting an EPS of $0.21, which topped the consensus estimate of -$0.42 by $0.63. Quarterly revenue was reported to be $71.75 million, above analysts' expectations of $15 million. With a trailing EPS of -$0.63, Poseida Therapeutics' earnings are expected to decrease next year, from ($1.02) to ($1.80) per share. Q3 2024 Earnings ResourcesQ3 2024 Earnings Report Press Release (8-K) Quarterly Report (10-Q)Powered by Get Poseida Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Poseida Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataPSTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.PSTX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Poseida Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.56-$0.34-$0.45Q2 20252-$0.59-$0.48-$0.54Q3 20252-$0.50-$0.45-$0.48Q4 20252-$0.52-$0.10-$0.31FY 20258($2.17)($1.37)($1.77) Poseida Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/7/2024--$0.42$0.21+$0.63$0.21$15.00M$71.75M8/5/2024--$0.43-$0.32+$0.11-$0.32$13.75M$25.97M5/14/2024Q1 2024-$0.43-$0.25+$0.18-$0.25$11.25M$28.14M3/7/2024Q4 2023-$0.36-$0.27+$0.09-$0.27$12.50M$25.00M11/9/2023Q3 2023-$0.29-$0.35 -$0.06-$0.35$11.50M$9.35M8/8/2023Q2 2023-$0.53-$0.32+$0.21-$0.32$10.00M$20.01M5/9/2023Q1 2023-$0.40-$0.45 -$0.05-$0.45$10.00M$10.34M Poseida Therapeutics Earnings - Frequently Asked Questions When did Poseida Therapeutics announce their last quarterly earnings? Poseida Therapeutics (NASDAQ:PSTX) last announced its quarterly earning data on Thursday, November 7, 2024. Learn more on PSTX's earnings history. Did Poseida Therapeutics beat their earnings estimates last quarter? In the previous quarter, Poseida Therapeutics (NASDAQ:PSTX) reported $0.21 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.42) by $0.63. Learn more on analysts' earnings estimate vs. PSTX's actual earnings. How much revenue does Poseida Therapeutics generate each year? Poseida Therapeutics (NASDAQ:PSTX) has a recorded annual revenue of $150.86 million. How much profit does Poseida Therapeutics generate each year? Poseida Therapeutics (NASDAQ:PSTX) has a recorded net income of -$123.43 million. PSTX has generated -$0.63 earnings per share over the last four quarters. What is Poseida Therapeutics's EPS forecast for next year? Poseida Therapeutics's earnings are expected to decrease from ($1.02) per share to ($1.80) per share in the next year. More Earnings Resources from MarketBeat Related Companies PTCT Earnings Date ZLAB Earnings Date ACLX Earnings Date RARE Earnings Date RNA Earnings Date AKRO Earnings Date MRUS Earnings Date OGN Earnings Date MOR Earnings Date SWTX Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Archer Aviation Unveils NYC Network Ahead of Key Earnings Report3 Reasons to Like the Look of Amazon Ahead of EarningsTesla Stock Eyes Breakout With Earnings on DeckJohnson & Johnson Earnings Were More Good Than Bad—Time to Buy? Why Analysts Boosted United Airlines Stock Ahead of EarningsLamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions Ahead This page (NASDAQ:PSTX) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Poseida Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Poseida Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PSTX Stock Free PSTX Stock Alerts